The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme
from Home Page https://ift.tt/3892Jjy
from Home Page https://ift.tt/3892Jjy
Comments
Post a Comment